CPHN.SW Stock Analysis
CP
Avoid
Based on Eyestock quantitative analysis, CPHN.SW`s fundamental data and valuation indicate an investment grade of Avoid at the current time.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Moderate score
Upside
To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.
Greatly overvalued
CPH Chemie + Papier Holding AG engages in the development, manufacture, and trade of chemicals, paper, and pharmaceutical packaging films. The company divides its activities into three divisions: Chemistry, Paper and Packaging. The Chemistry division is divided into fine chemistry, silicate chemistry and others. Fine chemistry product group focuses on production of organic chemicals for the pharmaceuticals industry. The silicate chemistry product group acts as a supplier of molecular sieves (zeolites) and silica gels for industrial applications. The Paper division focuses on production of newsprint primarily using raw materials and is divided into newsprint and magazine paper product groups. The packaging division provides full range of packaging products from PVC (polyvinyl chloride) monofilms to laminated high-barrier films that are primarily used in the manufacture of blister packs for medicinal products. Its major shareholder is UBV Uetikon Betriebs- & Verwaltungs AG with a stake of 49.9%.